Synergistic activity of the c-Met and tubulin inhibitor tivantinib (ARQ197) with pemetrexed in mesothelioma cells
Leticia G. Leon
PhD, PharmD
37th EORTC-PAMM Winter Meeting
Antwerp, Belgium
10 February 2016
Pdf: Synergistic activity of the c-Met and tubulin inhibitor tivantinib